No definition available.
Congenital malformations of eyelid, lacrimal apparatus and orbit
Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
336 |
4. Check minimum number of eventsNone |
336 |
5. Include endpointsNone |
336 |
6. Filter based on genotype QC (FinnGen only) |
336 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae palpebrarum, apparatus lacrimalis et orbitae
Similar endpoints
↥List of similar endpoints to
Congenital malformations of eyelid, lacrimal apparatus and orbit
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12033 | 5863 | 6168 |
| Only index persons | 7548 | 3712 | 3836 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.17 | 0.17 |
| Only index persons | 0.14 | 0.14 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 1.30 | 1.32 | 1.26 |
| Only index persons | 1.36 | 1.40 | 1.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 336 | 199 | 137 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | 2.98 | 1.85 | 4.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 304
- Matched controls
- 3048
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q10.5
ICD-10 Finland
Congenital stenosis and stricture of lacrimal duct
+∞
183.4
157
*
Q10.0
ICD-10 Finland
Congenital ptosis
+∞
132.1
117
*
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
550.4
86.7
82
*
H02.4
ICD-10 Finland
Ptosis of eyelid
62.3
45.3
52
10
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
178.0
31.3
32
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
35.7
27.5
35
11
CCA20
NOMESCO Finland
Incision of lacrimal punctum or canaliculus
76.6
25.3
28
*
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
+∞
20.0
19
*
74482
ICD-8 Finland
Congenital anomalies of eye, Ptosis
+∞
17.9
17
*
Q10.30
ICD-10 Finland
Other congenital malformations of eyelid
+∞
16.8
16
*
ZXA10
NOMESCO Finland
Bilateral
3.6
14.4
73
248
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
146.2
13.6
14
*
Q10.2
ICD-10 Finland
Congenital entropion
+∞
10.5
10
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
9.6
79
362
XCK10
NOMESCO Finland
Photography of fundus of eye
4.4
8.6
30
73
CBJ99
NOMESCO Finland
Other operation for ptosis
+∞
8.4
8
*
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
82.0
7.4
8
*
7436B
ICD-9 Finland
Congenital anomalies of eyelids, lachrymal system and orbit[PTOSIS CONGENITA]
+∞
7.3
7
*
3242
FHL
Levator resection
+∞
7.3
7
*
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
30.8
7.2
9
*
WX400
NOMESCO Finland
Inhalation anesthesy
3.7
6.9
29
84
ZXA00
NOMESCO Finland
Right side
2.5
6.8
57
260
H02.3
ICD-10 Finland
Blepharochalasis
7.4
6.8
15
21
Q10.1
ICD-10 Finland
Congenital ectropion
+∞
6.3
6
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
+∞
6.3
6
*
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
4.2
6.2
22
55
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.8
6.1
16
29
ZXA05
NOMESCO Finland
Left side
2.4
6.0
53
249
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
31
152
2.14
3.59
1.7
2.1
11.9
12.8
iu/l
0.10
26
120
294
2664
1.83
3.35
11.7
11.3
24.9
21.5
mg/l
0.73
219
1934
8
15
5.43
3.21
1.6
1.7
135.6
124.7
%
—
8
15
5
6
8.43
2.75
1.0
1.7
—
—
—
0
0
29
156
1.94
2.66
1.9
2.2
6.6
6.9
u/l
0.08
23
122
30
166
1.89
2.54
1.4
2.1
10.1
12.6
nmol/l
0.61
25
147
39
241
1.70
2.32
1.6
1.6
932.9
1135.6
nmol/l
1.04
31
178
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
18
3.95
2.26
1.9
1.7
120.3
108.9
%
—
7
18
37
229
1.69
2.19
1.4
1.4
262.1
361.3
u/ml
0.22
31
214
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
10
5.05
2.07
3.6
1.3
62.0
126.8
%
—
5
10
0
57
0.00
2.07
0.0
1.4
—
—
—
0
0
21
114
1.90
1.92
2.4
1.3
—
—
—
0
0
104
836
1.35
1.75
3.9
4.0
—
—
—
0
0
221
1981
1.34
1.74
3.4
3.4
14.7
14.5
pmol/l
0.53
201
1789
80
620
1.38
1.68
2.5
2.6
48.9
57.6
u/l
1.62
74
563
86
676
1.37
1.66
1.9
1.6
96.9
96.5
pmol/l
0.02
48
353
264
2443
1.37
1.60
13.3
12.6
3.9
3.9
mmol/l
0.47
258
2364
43
300
1.50
1.59
2.2
2.3
2904.1
3186.6
u/l
0.03
13
93
41
286
1.49
1.52
2.7
2.8
18.8
23.9
%
1.71
34
262
9
37
2.47
1.49
3.8
3.7
82.7
98.5
%
—
9
37
9
37
2.47
1.49
1.4
1.4
—
—
—
0
0
88
709
1.33
1.44
3.4
3.8
0.4
0.3
e6/l
0.13
69
529
124
1048
1.29
1.43
5.4
7.0
17.6
18.5
umol/l
0.08
114
978
285
2687
1.40
1.40
13.3
13.0
39.4
40.1
%
0.73
228
2271
262
2441
1.33
1.37
13.5
12.6
139.5
139.5
mmol/l
0.17
256
2367
279
2625
1.37
1.36
7.9
8.5
24.6
25.3
u/l
0.34
274
2537
71
564
1.33
1.28
2.5
2.9
23.9
30.2
ng/l
0.23
35
281
119
1018
1.26
1.21
9.0
10.9
1.2
1.2
mmol/l
0.88
109
949
7
140
0.49
1.11
1.6
1.3
—
—
—
0
0
180
1632
1.22
1.04
6.2
6.2
91.8
93.3
u/l
0.11
175
1534
77
915
0.79
1.00
3.1
2.7
—
—
—
0
0
5
23
2.19
0.98
1.2
2.8
—
—
—
0
0
26
183
1.46
0.97
5.9
5.5
—
—
—
0
0
259
2447
1.25
0.97
15.8
14.6
13.3
13.3
%
0.06
253
2402
7
37
1.91
0.94
1.6
1.4
—
—
—
0
0
113
986
1.22
0.94
2.9
2.8
73.8
69.9
nmol/l
0.70
104
909
243
2294
1.21
0.84
4.2
4.0
1.9
1.9
mu/l
0.15
227
2138
148
1338
1.19
0.83
5.8
6.6
6.2
6.1
mmol/l
0.04
140
1219
15
97
1.57
0.82
10.3
16.5
0.7
0.7
%
0.01
15
97
73
855
0.81
0.82
2.9
2.5
—
—
—
0
0
0
25
0.00
0.79
0.0
1.9
—
—
—
0
0
315
3069
1.42
0.79
18.3
16.2
134.8
135.3
g/l
0.26
310
3025
44
352
1.29
0.78
11.2
9.9
1.3
1.0
mmol/l
0.28
32
250
18
124
1.48
0.76
1.6
3.3
89.3
77.5
ml/min/173m2
—
8
51
6
34
1.78
0.76
1.7
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
4.1
—
—
—
0
0
0
28
0.00
0.76
0.0
4.1
—
—
—
0
0
46
373
1.27
0.74
11.7
14.9
24.9
24.5
mmol/l
0.48
46
373
44
355
1.28
0.74
11.2
9.9
5.2
5.1
kpa
0.43
44
340
175
1617
1.17
0.73
9.3
10.1
3.9
3.8
e9/l
0.10
155
1374
15
102
1.49
0.68
3.4
3.7
0.1
0.1
e6/l
0.26
15
96
19
136
1.42
0.68
1.8
1.8
—
—
—
0
0
121
1092
1.17
0.67
9.0
10.4
1.2
1.2
mmol/l
0.94
108
966
32
251
1.30
0.67
2.2
1.8
—
—
—
0
0
56
471
1.23
0.67
2.8
3.6
1.2
1.3
mg/l
0.02
32
336
144
1318
1.16
0.66
3.6
3.1
79.6
64.0
ug/l
0.62
134
1233
5
28
1.80
0.66
1.4
1.3
—
—
—
0
0
37
298
1.27
0.64
11.8
10.4
9.1
9.5
kpa
0.57
37
285
51
428
1.23
0.63
3.3
3.5
1.2
1.0
e6/l
0.26
32
241
68
588
1.20
0.62
4.5
3.0
1.0
1.0
kg/l
0.38
14
87
23
174
1.35
0.61
6.1
7.5
74.3
62.4
ng/l
0.26
18
163
21
157
1.36
0.60
8.2
14.7
14.7
13.9
kpa
0.21
21
152
21
157
1.36
0.60
8.2
14.7
5.4
5.2
kpa
0.28
21
151
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
6
35
1.73
0.58
1.5
1.8
—
—
—
0
0
49
414
1.21
0.57
1.3
1.4
—
—
—
0
0
9
60
1.51
0.54
2.0
1.5
—
—
—
0
0
39
325
1.23
0.52
3.7
4.8
6.2
8.3
umol/l
0.52
32
267
9
65
1.39
0.51
1.3
1.6
—
—
—
0
0
114
1044
1.14
0.51
4.2
4.4
—
—
—
0
0
206
1960
1.13
0.49
3.5
3.1
5.5
5.6
mmol/l
0.39
185
1804
21
163
1.31
0.49
1.2
1.2
0.1
1.9
u/ml
1.62
12
91
73
649
1.16
0.49
3.2
2.3
2.7
2.7
mg/l
0.06
66
561
7
49
1.44
0.46
1.0
1.8
—
—
—
0
0
7
51
1.38
0.44
1.4
1.7
—
—
—
0
0
9
131
0.68
0.44
2.7
1.7
—
—
—
0
0
11
78
1.42
0.43
10.6
5.8
55.6
52.3
%
0.18
11
78
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
30
250
1.22
0.42
2.2
1.7
—
—
—
0
0
41
353
1.18
0.41
3.9
5.0
619.0
1020.7
ng/l
0.53
35
296
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
11
79
1.41
0.41
1.1
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
14
182
0.76
0.40
1.4
1.3
—
—
—
0
0
32
271
1.20
0.39
1.4
1.3
—
—
—
0
0
9
68
1.33
0.38
1.7
1.7
—
—
—
0
0
17
135
1.27
0.36
2.1
1.7
—
—
—
0
0
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
6
42
1.44
0.35
1.3
1.5
22.8
14.5
u/l
—
6
37
6
42
1.44
0.35
1.0
1.0
—
—
—
0
0
47
416
1.15
0.35
3.4
3.8
4.6
3.2
e6/l
0.28
28
232
6
43
1.40
0.35
1.5
1.6
—
—
—
0
0
46
407
1.15
0.34
1.6
1.4
16.6
20.6
nmol/l
1.36
40
348
6
44
1.37
0.34
1.7
4.0
—
—
—
0
0
6
47
1.28
0.32
1.8
1.9
—
—
—
0
0
251
2572
0.90
0.32
3.8
3.9
—
—
—
0
0
15
120
1.26
0.30
2.1
1.8
—
—
—
0
0
10
130
0.76
0.30
2.5
1.7
—
—
—
0
0
7
56
1.25
0.29
1.4
1.5
—
—
—
0
0
204
1973
1.09
0.28
9.2
8.8
102.2
100.6
ml/min/173m2
0.41
157
1467
16
194
0.82
0.28
3.8
3.8
24.6
21.7
%
—
10
77
21
177
1.20
0.28
3.2
2.8
—
—
—
0
0
8
66
1.22
0.27
1.0
1.5
—
—
—
0
0
61
561
1.11
0.26
2.4
2.2
—
—
—
0
0
201
1947
1.08
0.26
3.6
3.4
2.8
2.7
mmol/l
0.85
187
1825
9
73
1.24
0.25
1.0
1.3
—
—
—
0
0
9
73
1.24
0.25
1.3
1.5
—
—
—
0
0
9
73
1.24
0.25
1.0
1.3
—
—
—
0
0
39
350
1.13
0.25
2.1
1.8
—
—
—
0
0
11
87
1.27
0.24
1.1
1.1
0.1
0.6
u/ml
—
5
31
9
77
1.17
0.24
2.0
1.8
—
—
—
0
0
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
40
362
1.12
0.23
1.1
1.2
15.3
26.4
iu/ml
0.98
11
96
52
478
1.10
0.23
2.3
2.0
—
—
—
0
0
31
346
0.89
0.22
10.2
8.8
0.8
0.8
mmol/l
0.58
31
326
108
1132
0.93
0.22
1.9
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
10.2
—
0
11
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
6.0
—
163.9
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
25
282
0.88
0.21
1.6
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
2.1
—
0
8
41
376
1.10
0.19
6.1
9.3
0.8
1.1
mmol/l
0.24
31
280
6
51
1.18
0.19
1.0
1.3
—
11.8
—
0
8
21
237
0.88
0.18
4.6
5.4
308.0
264.2
u/l
0.22
21
230
7
60
1.17
0.18
1.3
1.2
—
—
—
0
0
16
138
1.17
0.17
2.1
1.7
—
—
—
0
0
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
10
82
1.23
0.17
1.1
1.2
—
—
—
0
0
19
167
1.15
0.17
13.3
17.8
1.1
1.1
mg/l
0.40
19
162
12
101
1.19
0.16
1.2
1.1
—
9.9
—
0
13
16
139
1.16
0.16
1.4
1.4
—
—
—
0
0
8
71
1.13
0.16
2.0
1.9
0.3
0.6
nmol/l
—
8
60
6
79
0.75
0.15
1.7
1.9
—
—
—
0
0
12
140
0.85
0.15
1.3
1.5
—
—
—
0
0
9
79
1.14
0.15
2.1
2.0
—
—
—
0
0
7
86
0.81
0.14
1.4
1.2
—
—
—
0
0
7
87
0.80
0.14
1.6
2.0
—
—
—
0
0
7
88
0.79
0.14
1.3
1.6
—
0.0
—
0
20
189
1850
1.05
0.14
3.1
3.0
1.2
1.2
mmol/l
0.07
175
1744
12
138
0.86
0.13
2.3
2.6
0.7
0.6
ug/l
—
7
86
10
117
0.85
0.13
1.2
1.3
—
—
—
0
0
123
1199
1.04
0.11
4.2
3.3
0.0
0.0
estimate
0.00
22
257
16
177
0.90
0.10
1.3
1.4
218.6
270.4
miu/ml
—
10
91
199
1959
1.04
0.10
3.4
3.2
4.5
4.4
mmol/l
0.30
185
1856
14
125
1.12
0.10
1.5
1.4
—
—
—
0
0
196
1932
1.03
0.09
3.4
3.1
1.4
1.4
mmol/l
0.58
184
1815
123
1203
1.03
0.09
5.9
4.6
0.0
0.0
estimate
0.00
24
266
12
134
0.89
0.09
1.3
1.6
—
—
—
0
0
30
283
1.07
0.08
1.0
1.0
—
—
—
0
0
179
1764
1.03
0.08
3.9
3.8
8.2
8.7
mm/h
0.32
163
1633
6
73
0.82
0.07
7.3
9.9
—
2985.7
—
0
9
8
74
1.08
0.07
1.5
3.2
3.7
3.4
mmol/l
—
8
69
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
9
85
1.06
0.07
1.4
1.2
—
—
—
0
0
33
345
0.95
0.06
1.3
1.2
15.4
4.9
u/ml
0.32
12
128
68
662
1.03
0.06
4.1
3.0
2.4
2.4
mmol/l
0.04
61
596
123
1211
1.02
0.05
4.2
3.3
0.0
0.0
estimate
0.00
20
258
92
903
1.03
0.05
4.3
3.1
—
—
—
0
0
13
120
1.09
0.05
1.0
1.0
7.0
8.3
mu/l
0.48
13
113
24
230
1.05
0.03
1.6
1.3
—
—
—
0
0
57
561
1.02
0.02
2.9
2.9
—
—
—
0
0
96
969
0.99
0.02
1.6
1.6
1.3
2.7
u/ml
0.76
20
199
167
1679
0.99
0.01
4.4
4.0
36.9
37.2
mmol/mol
0.17
154
1581
14
147
0.95
0.01
1.3
1.2
—
—
—
0
0
24
234
1.03
0.00
1.4
1.3
54.8
141.1
iu/ml
—
5
80
23
232
0.99
0.00
2.6
2.1
—
—
—
0
0
34
345
0.98
0.00
3.2
3.8
437.3
511.7
ng/l
0.08
13
199
65
653
0.99
0.00
4.7
3.4
0.0
0.0
estimate
0.00
23
252
26
258
1.01
0.00
5.2
4.3
1.8
1.7
ug/l
0.02
20
227
18
179
1.01
0.00
2.2
2.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
7
71
0.99
0.00
10.0
10.7
25.1
23.6
mmol/l
—
7
63
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT | 1.242 [0.85, 1.81] | 0.263 |
| Birth year | 1.0 [0.99, 1.01] | 0.939 |
During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 5131 females with Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT | 1.42 [1.06, 1.9] | 0.018 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 5456 males with Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.215% |
| 5 | 0.743% | 1.521% |
| 10 | 2.266% | 4.077% |
| 15 | 4.051% | 7.793% |
| 20 | 7.108% | 12.713% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT – Congenital malformations of eyelid, lacrimal apparatus and orbit
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data